Leukemia, Myelodysplasia, Transplantation

News

Treatment of CML continues to progress

Dr O’Brien listed standard-dose imatinib, high-dose imatinib, imatinib-based combinations, second generation tyrosine kinase inhibitors (TKIs) and...

News

Agent shows promise in acute leukemias

Delivering drugs in combination requires a certain balance, a balance that ensures the drugs act synergistically. And researchers say they have...

Pages